

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 9.44238270 |
| 2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.56100732 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 7.06986162 |
| 4 | lipoprotein transport (GO:0042953) | 6.98670234 |
| 5 | regulation of guanylate cyclase activity (GO:0031282) | 6.31444651 |
| 6 | regulation of bile acid biosynthetic process (GO:0070857) | 6.18121161 |
| 7 | NADH metabolic process (GO:0006734) | 5.99169947 |
| 8 | * urate metabolic process (GO:0046415) | 5.97577863 |
| 9 | intestinal absorption (GO:0050892) | 5.95457159 |
| 10 | lysine metabolic process (GO:0006553) | 5.88007984 |
| 11 | lysine catabolic process (GO:0006554) | 5.88007984 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.77178569 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 5.76957820 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.76957820 |
| 15 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.72492627 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 5.70164216 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.70164216 |
| 18 | * drug transmembrane transport (GO:0006855) | 5.61146952 |
| 19 | cysteine metabolic process (GO:0006534) | 5.59577154 |
| 20 | aromatic amino acid family catabolic process (GO:0009074) | 5.49454745 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 5.31953560 |
| 22 | tryptophan catabolic process (GO:0006569) | 5.31953560 |
| 23 | indole-containing compound catabolic process (GO:0042436) | 5.31953560 |
| 24 | uronic acid metabolic process (GO:0006063) | 5.14278387 |
| 25 | glucuronate metabolic process (GO:0019585) | 5.14278387 |
| 26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.08023271 |
| 27 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.05947802 |
| 28 | tryptophan metabolic process (GO:0006568) | 5.03840985 |
| 29 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.02587154 |
| 30 | hormone catabolic process (GO:0042447) | 4.92147277 |
| 31 | alpha-linolenic acid metabolic process (GO:0036109) | 4.86979842 |
| 32 | * drug transport (GO:0015893) | 4.81696051 |
| 33 | kynurenine metabolic process (GO:0070189) | 4.75619918 |
| 34 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.69676299 |
| 35 | endocrine process (GO:0050886) | 4.69676299 |
| 36 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.69676299 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 4.69407836 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.61408241 |
| 39 | sulfur amino acid catabolic process (GO:0000098) | 4.53424456 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.42648803 |
| 41 | diacylglycerol metabolic process (GO:0046339) | 4.40380209 |
| 42 | bile acid biosynthetic process (GO:0006699) | 4.38339924 |
| 43 | plasma lipoprotein particle assembly (GO:0034377) | 4.33771264 |
| 44 | vitamin transmembrane transport (GO:0035461) | 4.31664501 |
| 45 | response to mercury ion (GO:0046689) | 4.30041508 |
| 46 | serine family amino acid metabolic process (GO:0009069) | 4.26342889 |
| 47 | drug catabolic process (GO:0042737) | 4.26067143 |
| 48 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.22971157 |
| 49 | peptide hormone processing (GO:0016486) | 4.19683234 |
| 50 | short-chain fatty acid metabolic process (GO:0046459) | 4.17211865 |
| 51 | regulation of systemic arterial blood pressure (GO:0003073) | 4.16075743 |
| 52 | adhesion of symbiont to host cell (GO:0044650) | 4.16074867 |
| 53 | virion attachment to host cell (GO:0019062) | 4.16074867 |
| 54 | renal system process involved in regulation of blood volume (GO:0001977) | 4.11303101 |
| 55 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.07076380 |
| 56 | vitamin transport (GO:0051180) | 4.06474850 |
| 57 | glycosphingolipid catabolic process (GO:0046479) | 3.98925675 |
| 58 | sulfate transmembrane transport (GO:1902358) | 3.98074030 |
| 59 | regulation of cGMP biosynthetic process (GO:0030826) | 3.97985195 |
| 60 | lipoprotein metabolic process (GO:0042157) | 3.96891202 |
| 61 | acetyl-CoA metabolic process (GO:0006084) | 3.96593242 |
| 62 | quaternary ammonium group transport (GO:0015697) | 3.96450980 |
| 63 | fatty acid beta-oxidation (GO:0006635) | 3.96036744 |
| 64 | protein-lipid complex assembly (GO:0065005) | 3.93692758 |
| 65 | glycolipid catabolic process (GO:0019377) | 3.92161724 |
| 66 | aromatic amino acid family metabolic process (GO:0009072) | 3.91865637 |
| 67 | midgut development (GO:0007494) | 3.91607102 |
| 68 | exogenous drug catabolic process (GO:0042738) | 3.91251491 |
| 69 | digestion (GO:0007586) | 3.90572120 |
| 70 | alpha-amino acid catabolic process (GO:1901606) | 3.89178364 |
| 71 | complement activation, alternative pathway (GO:0006957) | 3.88233547 |
| 72 | regulation of protein activation cascade (GO:2000257) | 3.87198210 |
| 73 | valine metabolic process (GO:0006573) | 3.86664431 |
| 74 | drinking behavior (GO:0042756) | 3.83138906 |
| 75 | ethanol oxidation (GO:0006069) | 3.82592021 |
| 76 | glycerol metabolic process (GO:0006071) | 3.76515996 |
| 77 | glycine metabolic process (GO:0006544) | 3.76421528 |
| 78 | regulation of complement activation (GO:0030449) | 3.75124406 |
| 79 | fatty acid oxidation (GO:0019395) | 3.74822092 |
| 80 | urea cycle (GO:0000050) | 3.74393894 |
| 81 | urea metabolic process (GO:0019627) | 3.74393894 |
| 82 | cellular amino acid catabolic process (GO:0009063) | 3.71397919 |
| 83 | aspartate family amino acid catabolic process (GO:0009068) | 3.70213623 |
| 84 | adhesion of symbiont to host (GO:0044406) | 3.68740029 |
| 85 | carnitine metabolic process (GO:0009437) | 3.68677022 |
| 86 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.66818737 |
| 87 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.66737220 |
| 88 | bile acid metabolic process (GO:0008206) | 3.66672308 |
| 89 | serine family amino acid biosynthetic process (GO:0009070) | 3.65954167 |
| 90 | organic cation transport (GO:0015695) | 3.65834556 |
| 91 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.65618442 |
| 92 | lipid oxidation (GO:0034440) | 3.65480145 |
| 93 | cellular modified amino acid catabolic process (GO:0042219) | 3.63255899 |
| 94 | cellular biogenic amine catabolic process (GO:0042402) | 3.62598168 |
| 95 | amine catabolic process (GO:0009310) | 3.62598168 |
| 96 | phospholipid efflux (GO:0033700) | 3.62158654 |
| 97 | indolalkylamine metabolic process (GO:0006586) | 3.60584379 |
| 98 | citrulline biosynthetic process (GO:0019240) | 3.59271360 |
| 99 | fatty acid catabolic process (GO:0009062) | 3.58298348 |
| 100 | negative regulation of fibrinolysis (GO:0051918) | 3.58047660 |
| 101 | branched-chain amino acid metabolic process (GO:0009081) | 3.55791054 |
| 102 | response to nitrosative stress (GO:0051409) | 3.55180472 |
| 103 | bile acid and bile salt transport (GO:0015721) | 3.54690944 |
| 104 | omega-hydroxylase P450 pathway (GO:0097267) | 3.52922188 |
| 105 | L-ascorbic acid metabolic process (GO:0019852) | 3.52675097 |
| 106 | cellular response to nitric oxide (GO:0071732) | 3.51481627 |
| 107 | nitrogen cycle metabolic process (GO:0071941) | 3.50920788 |
| 108 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.50690624 |
| 109 | cellular ketone body metabolic process (GO:0046950) | 3.48243785 |
| 110 | phosphate ion transport (GO:0006817) | 3.46813071 |
| 111 | phosphate ion transmembrane transport (GO:0035435) | 3.45342428 |
| 112 | regulation of cholesterol esterification (GO:0010872) | 3.44996650 |
| 113 | vitamin A metabolic process (GO:0006776) | 3.44918263 |
| 114 | 2-oxoglutarate metabolic process (GO:0006103) | 3.43933867 |
| 115 | arginine metabolic process (GO:0006525) | 3.42816484 |
| 116 | aldehyde catabolic process (GO:0046185) | 3.42752588 |
| 117 | regulation of triglyceride catabolic process (GO:0010896) | 3.42001240 |
| 118 | triglyceride homeostasis (GO:0070328) | 3.41927845 |
| 119 | acylglycerol homeostasis (GO:0055090) | 3.41927845 |
| 120 | regulation of fibrinolysis (GO:0051917) | 3.41037006 |
| 121 | carboxylic acid catabolic process (GO:0046395) | 3.40398433 |
| 122 | organic acid catabolic process (GO:0016054) | 3.40398433 |
| 123 | fat-soluble vitamin metabolic process (GO:0006775) | 3.40384201 |
| 124 | alditol metabolic process (GO:0019400) | 3.39508295 |
| 125 | benzene-containing compound metabolic process (GO:0042537) | 3.37660334 |
| 126 | sulfate transport (GO:0008272) | 3.36270726 |
| 127 | ceramide catabolic process (GO:0046514) | 3.35116128 |
| 128 | cellular glucuronidation (GO:0052695) | 3.34823302 |
| 129 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.34071888 |
| 130 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.34071888 |
| 131 | regulation of cholesterol homeostasis (GO:2000188) | 3.34008878 |
| 132 | monocarboxylic acid catabolic process (GO:0072329) | 3.33531739 |
| 133 | glutamate metabolic process (GO:0006536) | 3.33423992 |
| 134 | tricarboxylic acid metabolic process (GO:0072350) | 3.32763030 |
| 135 | branched-chain amino acid catabolic process (GO:0009083) | 3.32334968 |
| 136 | amino-acid betaine transport (GO:0015838) | 3.32334967 |
| 137 | carnitine transport (GO:0015879) | 3.32334967 |
| 138 | regulation of protein glycosylation (GO:0060049) | 3.31965998 |
| 139 | regulation of cellular extravasation (GO:0002691) | 3.31499302 |
| 140 | glycosylceramide metabolic process (GO:0006677) | 3.30498536 |
| 141 | sulfur compound transport (GO:0072348) | 3.30333705 |
| 142 | vitamin D metabolic process (GO:0042359) | 3.30208881 |
| 143 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.29215394 |
| 144 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.29215394 |
| 145 | flavonoid metabolic process (GO:0009812) | 3.28500537 |
| 146 | transcytosis (GO:0045056) | 3.25667925 |
| 147 | tyrosine metabolic process (GO:0006570) | 3.24899375 |
| 148 | neutral amino acid transport (GO:0015804) | 3.24713228 |
| 149 | cGMP-mediated signaling (GO:0019934) | 3.22947889 |
| 150 | regulation of cGMP metabolic process (GO:0030823) | 3.22499822 |
| 151 | high-density lipoprotein particle remodeling (GO:0034375) | 3.22229996 |
| 152 | protein carboxylation (GO:0018214) | 3.20924210 |
| 153 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.20924210 |
| 154 | drug metabolic process (GO:0017144) | 3.18782745 |
| 155 | sphingomyelin metabolic process (GO:0006684) | 3.18336523 |
| 156 | reverse cholesterol transport (GO:0043691) | 3.16793562 |
| 157 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.16621347 |
| 158 | cholesterol homeostasis (GO:0042632) | 3.15010999 |
| 159 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.14877034 |
| 160 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.11117379 |
| 161 | sterol homeostasis (GO:0055092) | 3.09558012 |
| 162 | positive regulation of lipid catabolic process (GO:0050996) | 3.08423359 |
| 163 | sphingolipid catabolic process (GO:0030149) | 3.07772220 |
| 164 | response to phenylpropanoid (GO:0080184) | 3.07597860 |
| 165 | fatty acid transmembrane transport (GO:1902001) | 3.07460673 |
| 166 | peptide catabolic process (GO:0043171) | 3.06617657 |
| 167 | cellular response to reactive nitrogen species (GO:1902170) | 3.06504043 |
| 168 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.06268978 |
| 169 | regulation of vitamin metabolic process (GO:0030656) | 3.05911718 |
| 170 | vitamin biosynthetic process (GO:0009110) | 3.04511985 |
| 171 | alkaloid metabolic process (GO:0009820) | 3.03441599 |
| 172 | fructose metabolic process (GO:0006000) | 3.03259824 |
| 173 | proline metabolic process (GO:0006560) | 3.02064682 |
| 174 | glycoside metabolic process (GO:0016137) | 3.01057223 |
| 175 | glycine transport (GO:0015816) | 2.98771540 |
| 176 | membrane lipid catabolic process (GO:0046466) | 2.95633589 |
| 177 | modified amino acid transport (GO:0072337) | 2.95595268 |
| 178 | cholesterol efflux (GO:0033344) | 2.94001780 |
| 179 | mRNA modification (GO:0016556) | 2.93130882 |
| 180 | macromolecular complex remodeling (GO:0034367) | 2.92830056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.13337117 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.28175705 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.60925593 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.47303815 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.47250596 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.84379248 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.78077039 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.24617173 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.02597052 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.77117738 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.71463853 |
| 12 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.70079574 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.59852183 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.47153137 |
| 15 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.43048454 |
| 16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.34548835 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.18891953 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.18889204 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16001477 |
| 20 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.00868847 |
| 21 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.99543923 |
| 22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.82157189 |
| 23 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.80181357 |
| 24 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.73666362 |
| 25 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.69702514 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64412607 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.64082516 |
| 28 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.62822455 |
| 29 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.60280666 |
| 30 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.49857949 |
| 31 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.46973428 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.44685869 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41818872 |
| 34 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.36710494 |
| 35 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.36103640 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35406351 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.34569126 |
| 38 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.34368886 |
| 39 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.34326146 |
| 40 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.33469332 |
| 41 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.32500938 |
| 42 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28630286 |
| 43 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.26909463 |
| 44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.26703776 |
| 45 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.26151329 |
| 46 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22886403 |
| 47 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.22217013 |
| 48 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20550538 |
| 49 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.20227782 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19758251 |
| 51 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.18398218 |
| 52 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.18056133 |
| 53 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16479658 |
| 54 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.15929343 |
| 55 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.15006753 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13838748 |
| 57 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.12855624 |
| 58 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11393767 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09997502 |
| 60 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08630199 |
| 61 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06410820 |
| 62 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.04770194 |
| 63 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02415003 |
| 64 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01974051 |
| 65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01260481 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01003034 |
| 67 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00655138 |
| 68 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00654692 |
| 69 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00608187 |
| 70 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.99749574 |
| 71 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.98560450 |
| 72 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.97920765 |
| 73 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97698356 |
| 74 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.97412296 |
| 75 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.96892333 |
| 76 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96481944 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95947596 |
| 78 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.95932413 |
| 79 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95552876 |
| 80 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95046342 |
| 81 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.94419673 |
| 82 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.93663553 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93349674 |
| 84 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92913067 |
| 85 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92002176 |
| 86 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91544919 |
| 87 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91231109 |
| 88 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.89512112 |
| 89 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.88941437 |
| 90 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87996544 |
| 91 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.87486364 |
| 92 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86362605 |
| 93 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86270868 |
| 94 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.85904897 |
| 95 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.85683792 |
| 96 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85485040 |
| 97 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84446334 |
| 98 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.83925659 |
| 99 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83835780 |
| 100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.83330562 |
| 101 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82495653 |
| 102 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82319153 |
| 103 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.81229042 |
| 104 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.79060465 |
| 105 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.79005158 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78770931 |
| 107 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.78122192 |
| 108 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77170153 |
| 109 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.77132442 |
| 110 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.77132442 |
| 111 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.76992665 |
| 112 | CBP_21632823_ChIP-Seq_H3396_Human | 0.76117601 |
| 113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.74947304 |
| 114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.74594968 |
| 115 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74475817 |
| 116 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.73417338 |
| 117 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.71910796 |
| 118 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.71179500 |
| 119 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.71137805 |
| 120 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71109436 |
| 121 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.70664689 |
| 122 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.69712709 |
| 123 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.69528359 |
| 124 | CJUN_26792858_Chip-Seq_BT549_Human | 0.68840504 |
| 125 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.68674442 |
| 126 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.68661532 |
| 127 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68506335 |
| 128 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.68168752 |
| 129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.68147537 |
| 130 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.68009237 |
| 131 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.67373606 |
| 132 | AR_20517297_ChIP-Seq_VCAP_Human | 0.64753950 |
| 133 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.64530142 |
| 134 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63773383 |
| 135 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.63232672 |
| 136 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.62299585 |
| 137 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61466502 |
| 138 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60722194 |
| 139 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.60600040 |
| 140 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.60528243 |
| 141 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.59740213 |
| 142 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.59151211 |
| 143 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.59129265 |
| 144 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.59089443 |
| 145 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.59082965 |
| 146 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58980231 |
| 147 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.58339069 |
| 148 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.56004538 |
| 149 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.55942679 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.32028364 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.08996251 |
| 3 | * MP0005085_abnormal_gallbladder_physiolo | 4.41796773 |
| 4 | MP0005365_abnormal_bile_salt | 4.26464287 |
| 5 | MP0003183_abnormal_peptide_metabolism | 4.19021317 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.73383816 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.46422684 |
| 8 | MP0004019_abnormal_vitamin_homeostasis | 3.13839355 |
| 9 | MP0003252_abnormal_bile_duct | 3.07110318 |
| 10 | MP0005332_abnormal_amino_acid | 2.98465310 |
| 11 | * MP0004147_increased_porphyrin_level | 2.89082447 |
| 12 | MP0005409_darkened_coat_color | 2.72274354 |
| 13 | MP0010368_abnormal_lymphatic_system | 2.43201596 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.40856524 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.26196990 |
| 16 | MP0009643_abnormal_urine_homeostasis | 2.18685955 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.18237320 |
| 18 | MP0003656_abnormal_erythrocyte_physiolo | 2.12675828 |
| 19 | MP0001664_abnormal_digestion | 1.98041717 |
| 20 | MP0003879_abnormal_hair_cell | 1.96570746 |
| 21 | MP0005636_abnormal_mineral_homeostasis | 1.92020375 |
| 22 | MP0003186_abnormal_redox_activity | 1.83644568 |
| 23 | MP0003195_calcinosis | 1.81842122 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.81744883 |
| 25 | MP0005083_abnormal_biliary_tract | 1.81291060 |
| 26 | MP0001879_abnormal_lymphatic_vessel | 1.80601225 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.79721191 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.76309634 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.76279115 |
| 30 | MP0006054_spinal_hemorrhage | 1.72108816 |
| 31 | MP0009697_abnormal_copulation | 1.68567964 |
| 32 | MP0005084_abnormal_gallbladder_morpholo | 1.62089590 |
| 33 | MP0001756_abnormal_urination | 1.60671340 |
| 34 | MP0000609_abnormal_liver_physiology | 1.55656625 |
| 35 | MP0004270_analgesia | 1.54471810 |
| 36 | MP0003866_abnormal_defecation | 1.54152440 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.52069714 |
| 38 | MP0009379_abnormal_foot_pigmentation | 1.51408476 |
| 39 | MP0004043_abnormal_pH_regulation | 1.49370570 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.44090830 |
| 41 | MP0005670_abnormal_white_adipose | 1.40323999 |
| 42 | MP0002136_abnormal_kidney_physiology | 1.35236843 |
| 43 | MP0005166_decreased_susceptibility_to | 1.34702420 |
| 44 | MP0003724_increased_susceptibility_to | 1.30994737 |
| 45 | * MP0001764_abnormal_homeostasis | 1.30066765 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.27164018 |
| 47 | MP0004272_abnormal_basement_membrane | 1.22817478 |
| 48 | MP0001765_abnormal_ion_homeostasis | 1.20976690 |
| 49 | MP0000598_abnormal_liver_morphology | 1.20817447 |
| 50 | MP0002098_abnormal_vibrissa_morphology | 1.12780564 |
| 51 | MP0001881_abnormal_mammary_gland | 1.12606704 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 1.12215872 |
| 53 | MP0005408_hypopigmentation | 1.10821930 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.10648078 |
| 55 | MP0009840_abnormal_foam_cell | 1.09194196 |
| 56 | MP0003868_abnormal_feces_composition | 1.08457622 |
| 57 | MP0005666_abnormal_adipose_tissue | 1.02913168 |
| 58 | MP0003300_gastrointestinal_ulcer | 1.02835804 |
| 59 | MP0003705_abnormal_hypodermis_morpholog | 1.01732732 |
| 60 | MP0005448_abnormal_energy_balance | 1.01217429 |
| 61 | MP0004782_abnormal_surfactant_physiolog | 1.01072994 |
| 62 | MP0000462_abnormal_digestive_system | 0.95876176 |
| 63 | MP0005535_abnormal_body_temperature | 0.95765964 |
| 64 | MP0008872_abnormal_physiological_respon | 0.95015673 |
| 65 | MP0009764_decreased_sensitivity_to | 0.94436948 |
| 66 | MP0004264_abnormal_extraembryonic_tissu | 0.94077403 |
| 67 | MP0009115_abnormal_fat_cell | 0.88290402 |
| 68 | MP0002009_preneoplasia | 0.84363558 |
| 69 | MP0003878_abnormal_ear_physiology | 0.83765399 |
| 70 | MP0005377_hearing/vestibular/ear_phenot | 0.83765399 |
| 71 | MP0000230_abnormal_systemic_arterial | 0.83385332 |
| 72 | MP0001958_emphysema | 0.81303753 |
| 73 | MP0009763_increased_sensitivity_to | 0.80073572 |
| 74 | MP0005647_abnormal_sex_gland | 0.79167551 |
| 75 | MP0003329_amyloid_beta_deposits | 0.78714120 |
| 76 | * MP0005376_homeostasis/metabolism_phenot | 0.77240343 |
| 77 | MP0003943_abnormal_hepatobiliary_system | 0.77220743 |
| 78 | MP0008260_abnormal_autophagy | 0.76561370 |
| 79 | MP0000538_abnormal_urinary_bladder | 0.76283895 |
| 80 | MP0008469_abnormal_protein_level | 0.75787415 |
| 81 | MP0003718_maternal_effect | 0.75331018 |
| 82 | MP0001542_abnormal_bone_strength | 0.74086045 |
| 83 | * MP0009642_abnormal_blood_homeostasis | 0.73039364 |
| 84 | MP0003011_delayed_dark_adaptation | 0.71906844 |
| 85 | MP0005397_hematopoietic_system_phenotyp | 0.70698270 |
| 86 | MP0001545_abnormal_hematopoietic_system | 0.70698270 |
| 87 | MP0005266_abnormal_metabolism | 0.68420814 |
| 88 | MP0002135_abnormal_kidney_morphology | 0.67400827 |
| 89 | MP0010352_gastrointestinal_tract_polyps | 0.67151477 |
| 90 | MP0002928_abnormal_bile_duct | 0.66353596 |
| 91 | MP0009053_abnormal_anal_canal | 0.63278847 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.63227024 |
| 93 | MP0010678_abnormal_skin_adnexa | 0.63208150 |
| 94 | MP0005395_other_phenotype | 0.63144504 |
| 95 | MP0002796_impaired_skin_barrier | 0.61127377 |
| 96 | MP0004130_abnormal_muscle_cell | 0.60910356 |
| 97 | MP0003953_abnormal_hormone_level | 0.60269185 |
| 98 | MP0000537_abnormal_urethra_morphology | 0.60183119 |
| 99 | MP0004484_altered_response_of | 0.59979027 |
| 100 | MP0005165_increased_susceptibility_to | 0.59168651 |
| 101 | MP0003638_abnormal_response/metabolism_ | 0.58133774 |
| 102 | MP0008775_abnormal_heart_ventricle | 0.57721664 |
| 103 | MP0001873_stomach_inflammation | 0.57668632 |
| 104 | MP0009384_cardiac_valve_regurgitation | 0.57645334 |
| 105 | MP0000604_amyloidosis | 0.56573542 |
| 106 | MP0005464_abnormal_platelet_physiology | 0.56083118 |
| 107 | MP0006138_congestive_heart_failure | 0.55198163 |
| 108 | MP0005058_abnormal_lysosome_morphology | 0.54158129 |
| 109 | MP0003045_fibrosis | 0.53970595 |
| 110 | MP0000249_abnormal_blood_vessel | 0.53239881 |
| 111 | MP0000013_abnormal_adipose_tissue | 0.53084513 |
| 112 | MP0001661_extended_life_span | 0.52949999 |
| 113 | MP0000678_abnormal_parathyroid_gland | 0.52773495 |
| 114 | MP0001188_hyperpigmentation | 0.52139281 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.51284527 |
| 116 | MP0005330_cardiomyopathy | 0.51002739 |
| 117 | MP0001663_abnormal_digestive_system | 0.49965758 |
| 118 | MP0005164_abnormal_response_to | 0.49261112 |
| 119 | MP0005334_abnormal_fat_pad | 0.49139494 |
| 120 | MP0005451_abnormal_body_composition | 0.48770049 |
| 121 | MP0002822_catalepsy | 0.48583341 |
| 122 | MP0010307_abnormal_tumor_latency | 0.48146144 |
| 123 | MP0008004_abnormal_stomach_pH | 0.47527552 |
| 124 | MP0000767_abnormal_smooth_muscle | 0.46657657 |
| 125 | MP0003075_altered_response_to | 0.46563715 |
| 126 | MP0002128_abnormal_blood_circulation | 0.46537088 |
| 127 | MP0010234_abnormal_vibrissa_follicle | 0.45319728 |
| 128 | MP0000477_abnormal_intestine_morphology | 0.44883993 |
| 129 | MP0002971_abnormal_brown_adipose | 0.44687029 |
| 130 | * MP0005501_abnormal_skin_physiology | 0.44444713 |
| 131 | MP0005220_abnormal_exocrine_pancreas | 0.44138028 |
| 132 | MP0001485_abnormal_pinna_reflex | 0.43144822 |
| 133 | MP0008874_decreased_physiological_sensi | 0.43058288 |
| 134 | MP0000377_abnormal_hair_follicle | 0.42787836 |
| 135 | MP0002876_abnormal_thyroid_physiology | 0.42386815 |
| 136 | MP0000490_abnormal_crypts_of | 0.42117190 |
| 137 | MP0002166_altered_tumor_susceptibility | 0.41875870 |
| 138 | MP0005381_digestive/alimentary_phenotyp | 0.41577054 |
| 139 | MP0002896_abnormal_bone_mineralization | 0.41281463 |
| 140 | MP0002086_abnormal_extraembryonic_tissu | 0.41196116 |
| 141 | MP0002837_dystrophic_cardiac_calcinosis | 0.41096435 |
| 142 | MP0002168_other_aberrant_phenotype | 0.40712612 |
| 143 | MP0005595_abnormal_vascular_smooth | 0.40439088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.20115027 |
| 2 | Hyperglycinuria (HP:0003108) | 4.62076360 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.52579075 |
| 4 | Chronic diarrhea (HP:0002028) | 4.48067715 |
| 5 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.46657915 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.35929265 |
| 7 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.29551551 |
| 8 | Abnormality of vitamin B metabolism (HP:0004340) | 4.19804999 |
| 9 | Widely patent fontanelles and sutures (HP:0004492) | 4.19778978 |
| 10 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.11269986 |
| 11 | Xanthomatosis (HP:0000991) | 4.08371341 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 4.04603683 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.04603683 |
| 14 | Gout (HP:0001997) | 3.99905448 |
| 15 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.95215978 |
| 16 | Abnormality of purine metabolism (HP:0004352) | 3.94538202 |
| 17 | Deep venous thrombosis (HP:0002625) | 3.94382465 |
| 18 | Proximal tubulopathy (HP:0000114) | 3.90508983 |
| 19 | Hyperammonemia (HP:0001987) | 3.87257741 |
| 20 | Hyperglycinemia (HP:0002154) | 3.81722685 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.77941404 |
| 22 | Hypobetalipoproteinemia (HP:0003563) | 3.76542131 |
| 23 | Abnormality of vitamin metabolism (HP:0100508) | 3.72636087 |
| 24 | Abnormality of nucleobase metabolism (HP:0010932) | 3.58368358 |
| 25 | Generalized aminoaciduria (HP:0002909) | 3.57010502 |
| 26 | Pigmentary retinal degeneration (HP:0001146) | 3.49698330 |
| 27 | Complement deficiency (HP:0004431) | 3.48701304 |
| 28 | Ketosis (HP:0001946) | 3.48215562 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.48178618 |
| 30 | Prolonged partial thromboplastin time (HP:0003645) | 3.44756836 |
| 31 | Hyperbilirubinemia (HP:0002904) | 3.37748202 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.33984005 |
| 33 | Abdominal distention (HP:0003270) | 3.32287940 |
| 34 | Malnutrition (HP:0004395) | 3.26750039 |
| 35 | Increased purine levels (HP:0004368) | 3.17944601 |
| 36 | Hyperuricemia (HP:0002149) | 3.17944601 |
| 37 | Papilledema (HP:0001085) | 3.13582785 |
| 38 | Megaloblastic anemia (HP:0001889) | 3.11033236 |
| 39 | Decreased circulating renin level (HP:0003351) | 3.10070495 |
| 40 | Nausea (HP:0002018) | 3.09743085 |
| 41 | Fat malabsorption (HP:0002630) | 3.05953187 |
| 42 | Facial shape deformation (HP:0011334) | 3.03710043 |
| 43 | Potter facies (HP:0002009) | 3.03710043 |
| 44 | Wide cranial sutures (HP:0010537) | 3.02930299 |
| 45 | Ketoacidosis (HP:0001993) | 3.00987611 |
| 46 | Delayed CNS myelination (HP:0002188) | 3.00290090 |
| 47 | Hepatocellular carcinoma (HP:0001402) | 2.98328218 |
| 48 | Abnormality of renin-angiotensin system (HP:0000847) | 2.92682851 |
| 49 | Dicarboxylic aciduria (HP:0003215) | 2.90275587 |
| 50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.90275587 |
| 51 | Acanthocytosis (HP:0001927) | 2.89685559 |
| 52 | Congenital sensorineural hearing impairment (HP:0008527) | 2.89602716 |
| 53 | Hypokalemic alkalosis (HP:0001949) | 2.88292978 |
| 54 | Glycosuria (HP:0003076) | 2.87913523 |
| 55 | Abnormality of urine glucose concentration (HP:0011016) | 2.87913523 |
| 56 | Poikilocytosis (HP:0004447) | 2.87419898 |
| 57 | Alkalosis (HP:0001948) | 2.86274699 |
| 58 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.86028669 |
| 59 | Hypolipoproteinemia (HP:0010981) | 2.84321629 |
| 60 | Metabolic alkalosis (HP:0200114) | 2.84230091 |
| 61 | Thin bony cortex (HP:0002753) | 2.83844304 |
| 62 | Joint hemorrhage (HP:0005261) | 2.82506766 |
| 63 | Hypochromic microcytic anemia (HP:0004840) | 2.81566636 |
| 64 | Abnormality of serum amino acid levels (HP:0003112) | 2.79676758 |
| 65 | Right ventricular cardiomyopathy (HP:0011663) | 2.79380750 |
| 66 | Hyperactive renin-angiotensin system (HP:0000841) | 2.79147829 |
| 67 | Metabolic acidosis (HP:0001942) | 2.79036210 |
| 68 | Facial diplegia (HP:0001349) | 2.77804711 |
| 69 | Hyperlipoproteinemia (HP:0010980) | 2.76634502 |
| 70 | Increased circulating renin level (HP:0000848) | 2.74233367 |
| 71 | Abnormality of the intrinsic pathway (HP:0010989) | 2.71955528 |
| 72 | Abnormal urine output (HP:0012590) | 2.71620351 |
| 73 | Ileus (HP:0002595) | 2.70802668 |
| 74 | Polyuria (HP:0000103) | 2.70131715 |
| 75 | Posterior subcapsular cataract (HP:0007787) | 2.69198999 |
| 76 | Hypomagnesemia (HP:0002917) | 2.68784385 |
| 77 | Spastic diplegia (HP:0001264) | 2.68673139 |
| 78 | Abnormality of renal excretion (HP:0011036) | 2.67236190 |
| 79 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.66734121 |
| 80 | Abnormality of methionine metabolism (HP:0010901) | 2.62329667 |
| 81 | Confusion (HP:0001289) | 2.60184656 |
| 82 | Lethargy (HP:0001254) | 2.55030263 |
| 83 | Subcapsular cataract (HP:0000523) | 2.52486424 |
| 84 | Esophageal varix (HP:0002040) | 2.48956261 |
| 85 | Abnormality of chloride homeostasis (HP:0011422) | 2.47492069 |
| 86 | Abnormal urine phosphate concentration (HP:0012599) | 2.47481525 |
| 87 | Abnormality of the common coagulation pathway (HP:0010990) | 2.47241618 |
| 88 | Focal segmental glomerulosclerosis (HP:0000097) | 2.46424720 |
| 89 | Systemic lupus erythematosus (HP:0002725) | 2.45463611 |
| 90 | Hyperparathyroidism (HP:0000843) | 2.45233838 |
| 91 | Vomiting (HP:0002013) | 2.44459741 |
| 92 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.43667835 |
| 93 | Abnormality of magnesium homeostasis (HP:0004921) | 2.42947010 |
| 94 | Hypophosphatemia (HP:0002148) | 2.42675525 |
| 95 | Rickets (HP:0002748) | 2.42474856 |
| 96 | Renal tubular dysfunction (HP:0000124) | 2.41803240 |
| 97 | Abnormality of complement system (HP:0005339) | 2.37960979 |
| 98 | Vascular calcification (HP:0004934) | 2.37448942 |
| 99 | Epidermoid cyst (HP:0200040) | 2.37288872 |
| 100 | Cholelithiasis (HP:0001081) | 2.37028516 |
| 101 | Hypoalphalipoproteinemia (HP:0003233) | 2.36156162 |
| 102 | Abnormality of proline metabolism (HP:0010907) | 2.35675462 |
| 103 | Hydroxyprolinuria (HP:0003080) | 2.35675462 |
| 104 | Aortic aneurysm (HP:0004942) | 2.34823616 |
| 105 | Irritability (HP:0000737) | 2.33852375 |
| 106 | Steatorrhea (HP:0002570) | 2.31490098 |
| 107 | Enlarged kidneys (HP:0000105) | 2.28338789 |
| 108 | Polycythemia (HP:0001901) | 2.26998285 |
| 109 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.25948836 |
| 110 | Nephrolithiasis (HP:0000787) | 2.24802534 |
| 111 | Flat acetabular roof (HP:0003180) | 2.23585558 |
| 112 | Abnormal gallbladder morphology (HP:0012437) | 2.20381438 |
| 113 | Conjugated hyperbilirubinemia (HP:0002908) | 2.19616073 |
| 114 | Elevated alkaline phosphatase (HP:0003155) | 2.19553991 |
| 115 | Hypoglycemic seizures (HP:0002173) | 2.19498558 |
| 116 | Cardiovascular calcification (HP:0011915) | 2.18995184 |
| 117 | Enlarged epiphyses (HP:0010580) | 2.15005365 |
| 118 | Sensorimotor neuropathy (HP:0007141) | 2.14459049 |
| 119 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.14175603 |
| 120 | Reticulocytosis (HP:0001923) | 2.11085800 |
| 121 | Hypotension (HP:0002615) | 2.09175195 |
| 122 | Hypercholesterolemia (HP:0003124) | 2.08464240 |
| 123 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.08060086 |
| 124 | Renal tubular acidosis (HP:0001947) | 2.06790859 |
| 125 | Symptomatic seizures (HP:0011145) | 2.06726457 |
| 126 | Hyperaldosteronism (HP:0000859) | 2.06497631 |
| 127 | Pancreatitis (HP:0001733) | 2.05644264 |
| 128 | Hyperphosphaturia (HP:0003109) | 2.02736881 |
| 129 | Nonimmune hydrops fetalis (HP:0001790) | 2.00018068 |
| 130 | Abnormality of iron homeostasis (HP:0011031) | 1.97994622 |
| 131 | Delayed epiphyseal ossification (HP:0002663) | 1.95032527 |
| 132 | Abnormality of the costochondral junction (HP:0000919) | 1.93300937 |
| 133 | Ankle clonus (HP:0011448) | 1.92309891 |
| 134 | Growth hormone excess (HP:0000845) | 1.92052212 |
| 135 | Abnormal glucose tolerance (HP:0001952) | 1.91830285 |
| 136 | Hypokalemia (HP:0002900) | 1.91472242 |
| 137 | Villous atrophy (HP:0011473) | 1.90644159 |
| 138 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.90644159 |
| 139 | Glomerulosclerosis (HP:0000096) | 1.88430180 |
| 140 | Protuberant abdomen (HP:0001538) | 1.86579151 |
| 141 | Cerebral palsy (HP:0100021) | 1.83198978 |
| 142 | Curly hair (HP:0002212) | 1.82610428 |
| 143 | Skin nodule (HP:0200036) | 1.82326672 |
| 144 | Hemorrhage of the eye (HP:0011885) | 1.81401019 |
| 145 | Multiple lipomas (HP:0001012) | 1.80246046 |
| 146 | Abnormality of the periventricular white matter (HP:0002518) | 1.77311388 |
| 147 | Osteomalacia (HP:0002749) | 1.77013632 |
| 148 | Abnormal biliary tract morphology (HP:0012440) | 1.75345989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 5.27278479 |
| 2 | MYLK | 4.37744893 |
| 3 | BCKDK | 4.06007109 |
| 4 | KDR | 3.90452776 |
| 5 | WNK4 | 3.09414352 |
| 6 | TGFBR2 | 2.81650693 |
| 7 | WNK3 | 2.52154452 |
| 8 | OXSR1 | 2.43675999 |
| 9 | MAP3K2 | 2.13544936 |
| 10 | LATS2 | 2.12309764 |
| 11 | EIF2AK1 | 2.06151879 |
| 12 | TSSK6 | 2.04459066 |
| 13 | TGFBR1 | 2.02699050 |
| 14 | MAP3K12 | 2.02592076 |
| 15 | EPHA4 | 2.01618241 |
| 16 | PIK3CG | 1.97816573 |
| 17 | PDK2 | 1.96998120 |
| 18 | NME2 | 1.84887544 |
| 19 | FLT3 | 1.79839714 |
| 20 | PDK4 | 1.79213908 |
| 21 | PDK3 | 1.79213908 |
| 22 | STK38L | 1.71170657 |
| 23 | MAP3K10 | 1.67957087 |
| 24 | MAP2K3 | 1.65034495 |
| 25 | BMPR2 | 1.61362351 |
| 26 | PKN2 | 1.58500662 |
| 27 | MST1R | 1.55092943 |
| 28 | SIK1 | 1.54067570 |
| 29 | INSRR | 1.51803017 |
| 30 | NEK6 | 1.51338795 |
| 31 | FRK | 1.43454226 |
| 32 | GRK1 | 1.43266759 |
| 33 | NEK1 | 1.41993988 |
| 34 | PIK3CA | 1.38907056 |
| 35 | PBK | 1.36835357 |
| 36 | FGFR4 | 1.29332802 |
| 37 | PDPK1 | 1.19042728 |
| 38 | MET | 1.18184684 |
| 39 | MAPK11 | 1.17913281 |
| 40 | PAK2 | 1.17311451 |
| 41 | ERN1 | 1.16693854 |
| 42 | MAP3K3 | 1.13496155 |
| 43 | NEK9 | 1.12849055 |
| 44 | PRKAA2 | 1.12003337 |
| 45 | RIPK1 | 1.07285574 |
| 46 | NUAK1 | 1.04091345 |
| 47 | ERBB4 | 1.02123800 |
| 48 | CAMK1D | 1.00079173 |
| 49 | BMPR1B | 0.99657774 |
| 50 | ACVR1B | 0.97363978 |
| 51 | STK24 | 0.96703734 |
| 52 | PTK6 | 0.95250815 |
| 53 | PRKG2 | 0.94627400 |
| 54 | MAPKAPK3 | 0.93967296 |
| 55 | STK39 | 0.93800001 |
| 56 | ZAK | 0.93586749 |
| 57 | TTN | 0.89592931 |
| 58 | GSK3A | 0.88997118 |
| 59 | PRPF4B | 0.87305952 |
| 60 | DAPK2 | 0.85606402 |
| 61 | LRRK2 | 0.82398594 |
| 62 | CAMK2G | 0.81489015 |
| 63 | CAMK2D | 0.81091934 |
| 64 | LATS1 | 0.78301029 |
| 65 | PTK2B | 0.76042574 |
| 66 | CDK6 | 0.75741184 |
| 67 | MELK | 0.72097806 |
| 68 | TESK2 | 0.71816349 |
| 69 | EPHB2 | 0.69660927 |
| 70 | MATK | 0.69443529 |
| 71 | ABL2 | 0.69422602 |
| 72 | STK38 | 0.68673293 |
| 73 | CAMK2B | 0.68310149 |
| 74 | DDR2 | 0.68002395 |
| 75 | FGFR3 | 0.67401319 |
| 76 | MAP3K1 | 0.67271423 |
| 77 | LMTK2 | 0.67063324 |
| 78 | TBK1 | 0.66920267 |
| 79 | KSR2 | 0.66433486 |
| 80 | STK10 | 0.66299661 |
| 81 | PAK4 | 0.64303092 |
| 82 | NTRK3 | 0.63671275 |
| 83 | MAPK12 | 0.61226191 |
| 84 | WEE1 | 0.56991742 |
| 85 | TTK | 0.55645204 |
| 86 | PDK1 | 0.55337285 |
| 87 | TESK1 | 0.53246088 |
| 88 | STK3 | 0.52998761 |
| 89 | MAPK4 | 0.51938355 |
| 90 | TNIK | 0.50304500 |
| 91 | ICK | 0.49026575 |
| 92 | PINK1 | 0.48360324 |
| 93 | RPS6KB2 | 0.48131594 |
| 94 | IRAK3 | 0.48076135 |
| 95 | SCYL2 | 0.47246375 |
| 96 | PTK2 | 0.46518361 |
| 97 | AURKB | 0.45784916 |
| 98 | PRKCA | 0.45545826 |
| 99 | MAP3K8 | 0.45501264 |
| 100 | JAK2 | 0.44789201 |
| 101 | ERBB2 | 0.44036321 |
| 102 | BMX | 0.43874656 |
| 103 | PRKAA1 | 0.43756987 |
| 104 | AKT3 | 0.43723649 |
| 105 | TEC | 0.43588868 |
| 106 | DAPK1 | 0.43442237 |
| 107 | GRK6 | 0.43372751 |
| 108 | MAP3K7 | 0.42757229 |
| 109 | NLK | 0.41204662 |
| 110 | CASK | 0.40512665 |
| 111 | IGF1R | 0.39432854 |
| 112 | STK4 | 0.38577999 |
| 113 | MAP3K14 | 0.38542299 |
| 114 | MAP3K11 | 0.37041909 |
| 115 | PDGFRA | 0.36537649 |
| 116 | BRSK2 | 0.36002586 |
| 117 | EIF2AK2 | 0.35915231 |
| 118 | CDK4 | 0.35842372 |
| 119 | MAPK15 | 0.33310759 |
| 120 | MAP2K1 | 0.32683088 |
| 121 | TYK2 | 0.32394618 |
| 122 | MST4 | 0.31867149 |
| 123 | EPHA2 | 0.31100545 |
| 124 | JAK3 | 0.31064031 |
| 125 | FER | 0.30662240 |
| 126 | AKT2 | 0.30167627 |
| 127 | PRKCZ | 0.28836241 |
| 128 | MAPKAPK5 | 0.28630345 |
| 129 | PRKCD | 0.28301907 |
| 130 | MAP2K6 | 0.27231353 |
| 131 | SRC | 0.26642673 |
| 132 | IKBKE | 0.26365072 |
| 133 | VRK1 | 0.26022224 |
| 134 | EIF2AK3 | 0.25547575 |
| 135 | MUSK | 0.24771392 |
| 136 | MAP2K2 | 0.24660242 |
| 137 | IRAK2 | 0.24534254 |
| 138 | PRKCI | 0.24274568 |
| 139 | RPS6KB1 | 0.24012924 |
| 140 | DAPK3 | 0.23926611 |
| 141 | EEF2K | 0.23664154 |
| 142 | PRKACG | 0.23606554 |
| 143 | SGK223 | 0.23297287 |
| 144 | CAMK2A | 0.22839511 |
| 145 | PRKD3 | 0.21987225 |
| 146 | RET | 0.21556819 |
| 147 | TYRO3 | 0.18567617 |
| 148 | GRK5 | 0.16637190 |
| 149 | PRKD1 | 0.15079460 |
| 150 | PHKG2 | 0.14021897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.31877455 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.16199406 |
| 3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.92509027 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.74910888 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.67283765 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.61656122 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.55568809 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.52973779 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49790009 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28057903 |
| 11 | Peroxisome_Homo sapiens_hsa04146 | 2.27937219 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.27189782 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.25285384 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.23543238 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.12933352 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.07181306 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.07098946 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.03805445 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.01394415 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.99454596 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.95707998 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.93995760 |
| 23 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.88486236 |
| 24 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.84034443 |
| 25 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.79044403 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.75314285 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.69828899 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.69520241 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69233029 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62593867 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.58756089 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53743454 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.53237253 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.51195467 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.49079687 |
| 36 | * Bile secretion_Homo sapiens_hsa04976 | 1.49016800 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.47720005 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.46068044 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.42187438 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.39309959 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.37443754 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37056080 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.27639210 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25709829 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.23990462 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.23021355 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20340473 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19120545 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16949206 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.14290162 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12831996 |
| 52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.12088127 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09021970 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07224320 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.06758474 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05293230 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.02825214 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02427868 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.99742508 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97913674 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.94254635 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88464360 |
| 63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86854415 |
| 64 | * ABC transporters_Homo sapiens_hsa02010 | 0.84835897 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.79502806 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78526478 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77623531 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75469505 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.74599353 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72565526 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70035699 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65290541 |
| 73 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64174246 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.62303833 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60052308 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55672411 |
| 77 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.48495967 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.48155848 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47846506 |
| 80 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47752841 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39483914 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.37794812 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35405480 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32587676 |
| 85 | Insulin secretion_Homo sapiens_hsa04911 | 0.30623079 |
| 86 | Tight junction_Homo sapiens_hsa04530 | 0.29980380 |
| 87 | Ribosome_Homo sapiens_hsa03010 | 0.29630853 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26392856 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25232128 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23118785 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22862491 |
| 92 | DNA replication_Homo sapiens_hsa03030 | 0.18895247 |
| 93 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.18223970 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17982313 |
| 95 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.16339251 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.15434145 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.14725545 |
| 98 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.13978624 |
| 99 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.13955470 |
| 100 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.13939942 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.13457179 |
| 102 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.13297653 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.09759146 |
| 104 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08906256 |
| 105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.08820625 |
| 106 | Cocaine addiction_Homo sapiens_hsa05030 | 0.08486168 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.07651941 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07647924 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.07449689 |
| 110 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.07239282 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.06875358 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.06774984 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.06339560 |
| 114 | Other glycan degradation_Homo sapiens_hsa00511 | 0.04753896 |
| 115 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.04254212 |
| 116 | Proteasome_Homo sapiens_hsa03050 | 0.03332146 |
| 117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.02250750 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.01868472 |
| 119 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.01857539 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | 0.01159671 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | -0.0535939 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0375450 |
| 123 | Purine metabolism_Homo sapiens_hsa00230 | -0.0373716 |
| 124 | Malaria_Homo sapiens_hsa05144 | -0.0322188 |
| 125 | Mismatch repair_Homo sapiens_hsa03430 | -0.0307207 |
| 126 | Bladder cancer_Homo sapiens_hsa05219 | -0.0094395 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0062973 |

